Fernando José Magro Dias


AuthID: R-000-50A

Confirmed Publications: 280



61
TITLE: Is tofacitinib a game-changing drug for ulcerative colitis?
AUTHORS: Fernando Magro ; Maria Manuela Estevinho;
PUBLISHED: 2020, SOURCE: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, VOLUME: 8, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
62
TITLE: Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease  Full Text
AUTHORS: Couto, MR; Goncalves, P; Magro, F ; Martel, F ;
PUBLISHED: 2020, SOURCE: PHARMACOLOGICAL RESEARCH, VOLUME: 159
INDEXED IN: Scopus WOS CrossRef: 87
IN MY: ORCID
63
TITLE: Newborn Congenital Abnormalities and Inflammatory Bowel Disease: Unveiling an Unexplored Relationship  Full Text
AUTHORS: Fernando Magro ; Maria Manuela Estevinho;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
64
TITLE: Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
AUTHORS: Catia Rocha; Paula Lago; Samuel Fernandes; Luis Correia; Francisco Portela; Ana Isabel Vieira; Marta Patita; Bruno Arroja; Paula Ministro; Catarina Alves; Claudia Camila Dias ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
65
TITLE: Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study
AUTHORS: Mafalda Santiago ; Fernando Magro ; Luis Correia; Francisco Portela; Paula Ministro; Paula Lago; Eunice Trindade; Claudia Camila Dias ;
PUBLISHED: 2020, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
66
TITLE: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in inflammatory Bowel Disease  Full Text
AUTHORS: Pinto Lopes, P; Afonso, J; Pinto Lopes, R; Rocha, C; Lago, P; Goncalves, R; De Sousa, HT; Macedo, G ; Dias, CC ; Magro, F ;
PUBLISHED: 2020, SOURCE: INFLAMMATORY BOWEL DISEASES, VOLUME: 26, ISSUE: 11
INDEXED IN: Scopus WOS
IN MY: ORCID
67
TITLE: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease  Full Text
AUTHORS: Pedro Pinto-Lopes; Joana Afonso ; Rui Pinto-Lopes; Cátia Rocha; Paula Lago; Raquel Gonçalves; Helena Tavares De Sousa; Guilherme Macedo ; Cláudia Camila Dias ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: Inflammatory Bowel Diseases, VOLUME: 26, ISSUE: 11
INDEXED IN: CrossRef: 16
IN MY: ORCID
68
TITLE: The daily impact of COVID-19 in gastroenterology
AUTHORS: Magro, F ; Abreu, C ; Rahier, JF;
PUBLISHED: 2020, SOURCE: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, VOLUME: 8, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 33
IN MY: ORCID
69
TITLE: The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
AUTHORS: Estevinho, MM; Magro, F ;
PUBLISHED: 2020, SOURCE: GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, VOLUME: 27, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
70
TITLE: Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis
AUTHORS: Sousa, P; Estevinho, MM; Dias, CC ; Ministro, P; Kopylov, U; Danese, S; Peyrin Biroulet, L; Magro, F ;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
Page 7 of 28. Total results: 280.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service